Actively Recruiting

Phase 3
Age: 18Years - 80Years
All Genders
NCT06577519

Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

Led by Jiangsu vcare pharmaceutical technology co., LTD · Updated on 2024-10-01

1000

Participants Needed

1

Research Sites

120 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a multi-center, randomized, double-blind, double-dummy, parallel-controled, phase III trial, aiming to evaluate the effectiveness and safety of long-term continuous administration of Vicagrel capsules in ACS patients undergoing PCI.

CONDITIONS

Official Title

Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients between 18 and 80 years old, with no gender restrictions.
  • Diagnosed with acute coronary syndrome (ACS) and scheduled for percutaneous coronary intervention (PCI), including STEMI and NSTE-ACS (UA/NSTEMI).
  • Voluntarily sign the informed consent form and agree to follow all visit arrangements specified in the study protocol during the trial period.
Not Eligible

You will not qualify if you...

  • Expected survival time less than 12 months.
  • Severe liver dysfunction not caused by heart disease, with ALT or AST levels more than 3 times the upper limit of normal, or cirrhosis.
  • Pregnant or lactating women, or participants and their partners planning to become pregnant during the trial period.
  • Other reasons as determined by researchers that make participation unsuitable.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

General Hospital of Northern Theater Command of Chinese PLA

Shenyang, Liaoning, China, 110015

Actively Recruiting

Loading map...

Research Team

X

Xiaojuan Lai

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) | DecenTrialz